Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. (Q46861548)
Jump to navigation
Jump to search
scientific article published on 6 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. |
scientific article published on 6 December 2007 |
Statements
1 reference
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. (English)
1 reference
C-H Köhne
1 reference
J De Greve
1 reference
J T Hartmann
1 reference
I Lang
1 reference
P Vergauwe
1 reference
K Becker
1 reference
D Braumann
1 reference
E Joosens
1 reference
L Müller
1 reference
J Janssens
1 reference
C Bokemeyer
1 reference
P Reimer
1 reference
H Link
1 reference
E Späth-Schwalbe
1 reference
H-J Wilke
1 reference
H Bleiberg
1 reference
J Van Den Brande
1 reference
M Debois
1 reference
U Bethe
1 reference
E Van Cutsem
1 reference
6 December 2007
1 reference
1 reference
19
1 reference
5
1 reference
920-926
1 reference
Identifiers
1 reference
1 reference